Cost-analysis from real-world REDS study on dalbavancin in inpatient treatment of acute bacterial skin and skin structure infections
Introduction: Inpatient treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) involves a significant economic burden on the healthcare system. The aim of the present analysis was to estimate the expenditure, in terms of direct and indirect healthcare costs, for patients hospital...
Saved in:
| Main Authors: | Matteo Scortichini, Alessandro Ruggieri, Agnese Cattaneo, Patrizia Mascagni, Paolo Sciattella |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AboutScience Srl
2025-06-01
|
| Series: | Global & Regional Health Technology Assessment |
| Subjects: | |
| Online Access: | https://journals.aboutscience.eu/index.php/grhta/article/view/3363 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Using Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) in Obese Patients: A Real-Life, Single-Center Observational Study
by: Alessandra Oliva, et al.
Published: (2025-01-01) -
Strategies to Stabilize Dalbavancin in Aqueous Solutions; Section-2: The Effects of 2 Hydroxypropyl-β-Cyclodextrin and Acetate Buffer with and Without Divalent Metal Ions
by: Sardar M. Jakaria, et al.
Published: (2024-11-01) -
Bridging the Gap: A Systematic Review with Expert Opinion on the Use of Dalbavancin for In-Label and Off-Label Indications in Pediatric Patients
by: Désirée Caselli, et al.
Published: (2025-01-01) -
Review of oritavancin for the treatment of acute bacterial skin and skin structure infections
by: Ana Alejandra García Robles, et al.
Published: (2018-03-01) -
PHARMACOECONOMIC STUDY OF SKIN TESTS IN THE DIAGNOSTICS OF TUBERCULOSIS INFECTION
by: R. I. Yagudina, et al.
Published: (2015-03-01)